---
title: "Hengrui’s Obesity Drug Rivals Zepbound in Late-Stage China Trial"
date: 2025-07-16T03:00:44+08:00
categories: ["finance"]
tags: ["SHH:600276"]
summary: "Jiangsu Hengrui Pharmaceuticals Co. and its US partner said their obesity drug candidate succeeded in a late-stage China study, a key step toward securing approval as domestic biotech firms increasing"
source_url: "https://www.bloomberg.com/news/articles/2025-07-16/hengrui-s-obesity-drug-rivals-zepbound-in-late-stage-china-trial"
---

Jiangsu Hengrui Pharmaceuticals Co. and its US partner said their obesity drug candidate succeeded in a late-stage China study, a key step toward securing approval as domestic biotech firms increasingly challenge foreign rivals.

---

*来源: [原文链接](https://www.bloomberg.com/news/articles/2025-07-16/hengrui-s-obesity-drug-rivals-zepbound-in-late-stage-china-trial)*
